Fig. 1 · Structure

Documents & Downloads

NMS-1286937

Cat. No. A13045 CAS 1034616-18-6

PLK inhibitor

NMS-1286937 is an orally bioavailable, small-molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Target & Activity

Target Activity Value
PLK1 2 nM
PLK2 >10 μM
PLK3 >10 μM

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 1034616-18-6
Applications PLK inhibitor
Formula C24H27F3N8O3
Molecular Weight 532.52
Synonyms NMS-P937
SMILES
CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO Warmed: 38 mg/mL (71.36 mM)
Water Insoluble
Ethanol Warmed: 9 mg/mL

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...